Skip to main content
. 2021 Apr 28;17(1):37–53. doi: 10.17925/EE.2021.17.1.37

Figure 3: Therapeutic strategies in polycystic ovarian syndrome.

Figure 3:

decreased/reduced;increased.

AGEs = advanced glycated end-products; BP = blood pressure; CRP = C-reactive protein; DCI = D-chiro-inositol; ET-1 = endothelin 1; FFAs = free fatty acids; FMD = flow-mediated dilatation; GDM = gestational diabetes mellitus; HDL-C = high-density lipoprotein cholesterol; ICAM-1 = Intercellular adhesion molecule 1; IMT = intima-media thickness; ins = insulin; IR = insulin resistance; MI = myo-inositols; PCOS = polycystic ovary syndrome; ROS = reactive oxygen species; S/D = systolic/diastolic; TNF-α: tumour necrosis factor α; TZDs = thiazolidinediones; VCAM-1 = vascular cell adhesion protein 1.